Healthcare >> CEO Interviews >> October 17, 2003
STEPHEN G. SUDOVAR is President and Chief Executive Officer of EluSys
Therapeutics, Inc. He is a highly reputed industry veteran with
extensive experience in both large pharmaceutical companies and
entrepreneurial business management. Prior to his position at EluSys,
Mr. Sudovar was serving as the President of Roche Laboratories, Inc., a
US division of Hoffmann-LaRoche. In his 10 years at Roche, Mr. Sudovar
presided over a three-fold increase in the company's US revenues, a
substantial increase in its share of the US market, and the integration
of two pharmaceutical company acquisitions. Prior to his positions at
Roche, Mr. Sudovar founded Pracon, Inc., a healthcare consulting and
communications firm. As President and CEO he was responsible for the
profitable rapid growth of the company. Pracon virtually doubled in size
for each of the first seven years. Earlier in his career Mr. Sudovar was
selected by the President's Commission on Personnel Exchange to
participate in the President's Executive Interchange Program. As a
Presidential appointee, he worked as Deputy Administrator for planning
evaluation and legislation for the Environmental Protection Agency. He
received a special recognition award from the President of the United
States for his work while at the agency. Mr. Sudovar has been Chairman
of the Board of Directors of the National Pharmaceutical Council,
Chairman of the Marketing Section at PhRMA, Chairman of the Board of
Pracon, Inc., and a Board member of Hoffmann-LaRoche, Inc. Mr. Sudovar
received his BSD from St. Peter's College and his MBA from Fairleigh
Dickinson University. Profile
Mr. Sudovar: EluSys Therapeutics was founded in 1998 when we acquired
technology from the University of Virginia that was
